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INTRODUCTION
Over the last few years the incidence of tuberculosis has increased worldwide especially due to the increasing incidence of human immunodeficiency virus (HIV), 1 which is ultimately responsible for most deaths among these patients. 2, 3 In Portugal, tuberculosis is still an important health care issue, although its incidence has been dropping -with an estimate of 16.5 new cases for 100 000 inhabitants, with the majority of cases reported in the districts of Lisbon and Porto. 4 Cutaneous involvement, although classical, remains an uncommon presentation of tuberculosis, comprising only 1.0% -1.5% of all extra-pulmonary manifestations. [5] [6] [7] Cutaneous tuberculosis can be acquired exogenously (direct inoculation) or endogenously (contiguous infection or hematogenous dissemination) and can present a wide variety of clinical features. 8 
CASE REPORT
A 70-year-old caucasian female was seen with a 2-month-history of multiple, painful, erythematous, nodular, ulcerated and suppurative lesions in the groin area, bilaterally (Fig. 1) .
Physical examination revealed palpable inguinal lymphadenopathy on the right side, without any other significant clinical findings. The patient was afebrile and denied night sweats or other systemic symptoms, and had not traveled abroad.
Previous history was remarkable for HIV seropositivity diagnosed 8 years before, under antiretroviral therapy with a current CD4 count of 242/mm 3 , negative viral load, and stage-IIIB cervical cancer treated with a chemo-radiotherapy scheme that had finished 2 years before. Given the clinical picture described, the main diagnostic considerations included cutaneous metastases, mycobacterial and deep fungal infections. However, sexually transmitted diseases were also excluded, namely venereal lymphogranuloma, syphilis, gonorrhea, herpes virus and cytomegalovirus infections.
A skin biopsy showed a dermal tuberculoid granulomatous infiltrate with caseous necrosis, containing numerous multinucleated giant cells of the Langhans type accompanied by a rim of lymphocytes, plasma cells and occasional eosinophils ( release assay) test was also positive. A computed tomography scan showed contiguity between inguinal nodes and the overlying skin surface (Fig. 3) . Chest x-ray did not reveal any abnormality. The patient began treatment with a combination of pyrazinamide, isoniazid, ethambutol and rifampicin and her condition improved considerably in just two weeks of treatment. After 3 months of treatment only scarring was present (Fig. 4) .
DISCUSSION
Scrofuloderma is a variant of cutaneous tuberculosis resulting from endogenous spread of the infection from a contiguous underlying focus, usually a lymph node or bone, with breakdown of the skin. 9 The lesion starts as a subcutaneous, mobile nodule, which attaches to the overlying skin afterwards leading to abscess formation and purulent discharge. This clinical manifestation is classically described in young patients, 10 and is more often seen in the axillae, neck, groin and chest. 11, 12 It's mainly associated with a state of lower immunity, with accompanying lower number of lymphocytes present in the granulomas and higher bacillary counts.
It's interesting to note that other variants of cutaneous tuberculosis -such as lupus vulgaris and tuberculosis verrucosa cutis, are associated with higher and intermediate immunocompetence states, respectively. 13 Given the many clinical features of cutaneous tuberculosis and the fact that lesions resemble many other dermatological conditions, diagnosis can be difficult and requires correlation between clinical findings and diagnostic tests. In face of the delay in obtaining microbiological confirmation -4 weeks, PCR can be of value. It has high sensitivity and specificity, with results in less than 24 -48 hours. However, 
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a positive result may not always correspond to an active infection and a negative result does not exclude it. Therefore, despite its utility, clinical correlation in mandatory 14, 15 In the setting of compatible clinical and histological features, even without a microbiological confirmation, tuberculostatic treatment should be started and, in these cases, the response to treatment can support the diagnosis.
In our patient, on clinical grounds alone, there was a possibility of cutaneous metastases from cervical cancer, given her medical history. However, the presence of typical tuberculoid granulomas in the skin combined with positive PCR for MBT, pointed to scrofuloderma, even in the absence of positive FITE and PAS stainings on histopathology. This was ultimately confirmed by isolation of MBT on routine bacterial culture (Löwestein-Jensen medium) 4 weeks later. Sensitivity testing showed susceptibility to firstline tuberculostatics. The recommended treatment for cutaneous tuberculosis is the same as for systemic disease (two months of isoniazid, rifampin, ethambutol and pyrazinamide plus four months of isoniazid and rifampin). This scheme was carried out in our patient with good response.
This case is remarkable for several features: an uncommon presentation of tuberculosis -scrofuloderma -in a higher age group than average, maybe due to HIV-immunosuppression, with negative histochemical stain for mycobacteria in the cutaneous biopsy (unusual, although previously described), with a positive PCR for MBT and positive mycobacterial tissue culture.
Tuberculosis is still an important health issue and clinicians should be aware of atypical clinical presentations, especially in the context of immunosuppression. Timely investigation is key and can prevent further complications.
OBSERVATIONS
This case was presented as a clinical case report in the Congress: Reunião da Primavera -Sociedade Portuguesa de Dermatologia e Venereologia, Lisbon, 2-3 June 2017.
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RESUMO
A pneumonite granulomatosa é uma complicação rara da imunoterapia com bacillus Calmette-Guerin após administração intravesical de bacillus Calmette-Guerin. Os autores apresentam um caso incomum de um homem de 67 anos de idade que desenvolveu sintomas ligeiros e inespecíficos, após instilações de bacillus Calmette-Guerin intravesical. 
